Menu Close

Leaders in Alzheimer’s research herald the dawn of a new era in drug development based on biology of aging

A combination of drugs will be needed to effectively treat or prevent Alzheimer’s disease and leading experts say we have entered a new era of drug development that will deliver them. In an editorial published in the Journal of Prevention of Alzheimer’s Disease, the authors say the two most important factors driving us toward success are the wide range of new drug targets in development and the rapid development of Alzheimer’s biomarkers.